A61K 31/57
Substituted in position 17 beta by a chain of two carbon atoms
Official title: substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
A61K31/57 (Substituted in position 17 beta by a chain of two carbon atoms) appears on 4,466 US grants and 8,274 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,466
- Published applications
- 8,274
- Assignees
- 2,778
- Inventors
- 11,358
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 10 | 0 |
| 1978 | 6 | 0 |
| 1979 | 11 | 0 |
| 1980 | 8 | 0 |
| 1981 | 9 | 0 |
| 1982 | 11 | 0 |
| 1983 | 8 | 0 |
| 1984 | 8 | 0 |
| 1985 | 10 | 0 |
| 1986 | 9 | 0 |
| 1987 | 6 | 0 |
| 1988 | 10 | 0 |
| 1989 | 17 | 0 |
| 1990 | 25 | 0 |
| 1991 | 25 | 0 |
| 1992 | 28 | 0 |
| 1993 | 26 | 0 |
| 1994 | 23 | 0 |
| 1995 | 30 | 0 |
| 1996 | 53 | 0 |
| 1997 | 66 | 0 |
| 1998 | 90 | 0 |
| 1999 | 87 | 0 |
| 2000 | 71 | 0 |
| 2001 | 61 | 25 |
| 2002 | 66 | 105 |
| 2003 | 64 | 206 |
| 2004 | 36 | 191 |
| 2005 | 35 | 230 |
| 2006 | 42 | 248 |
| 2007 | 44 | 255 |
| 2008 | 43 | 231 |
| 2009 | 42 | 244 |
| 2010 | 86 | 235 |
| 2011 | 103 | 268 |
| 2012 | 139 | 300 |
| 2013 | 145 | 305 |
| 2014 | 228 | 408 |
| 2015 | 239 | 423 |
| 2016 | 207 | 410 |
| 2017 | 265 | 438 |
| 2018 | 256 | 431 |
| 2019 | 266 | 467 |
| 2020 | 262 | 439 |
| 2021 | 235 | 452 |
| 2022 | 211 | 425 |
| 2023 | 191 | 483 |
| 2024 | 198 | 421 |
| 2025 | 223 | 340 |
| 2026 | 121 | 294 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Nanostructure or microstructure and method for producing same6 Oct 2026US 12,751,923 B2The University of Tokyo
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- Methods of treating fibrotic liver diseases or conditions with indeglitazar29 Sep 2026US 12,746,225 B2Pleiogenix Inc.
- Method of treating SCLC and managing neutropenia29 Sep 2026US 12,746,240 B2Pharma Mar, S. A.
- Ensifentrine for decreasing the frequency/severity of COPD exacerbations15 Sep 2026US 12,734,139 B2Verona Pharma PLC
- Prolyl hydroxylase domain-containing protein (phd) inhibitors, combinations and uses thereof8 Oct 2026US 2026/0306471 A1Insilico Medicine IP Limited
- Inhaled statins as bronchodilators to improve lung function in respiratory diseases8 Oct 2026US 2026/0306477 A1Beth Israel Deaconess Medical Center, Inc.
- Compositions and methods for the treatment of congenital adrenal hyperplasia8 Oct 2026US 2026/0306485 A1Crinetics Pharmaceuticals, Inc.
- Misoprostol formulation for non-oral administration8 Oct 2026US 2026/0306508 A1Conceptra Biosciences, LLC
- Topical composition8 Oct 2026US 2026/0306512 A1Api Corporation
Most cited
By later US patents
- Wound dressing with conformable elastomeric wound contact layer1,263US 5,445,604 ASmith and Nephew Associated Companies Limited · 1995
- Method of treating androgen independent prostate cancer1,091US 9,040,574 B2Natrogen Therapeutics International, Inc. · 2015
- Anti-angiogenic compositions and methods of use968US 5,716,981 AAngiogenesis Technologies, Inc. · 1998
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001